Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1837, Issue 7, 2014, Pages 954-963

  Schurig Briccio, Lici A ^a   Yano, Takahiro ^b   Rubin, Harvey ^b   Gennis, Robert B ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bioenergetics electron transfer complex; Enzyme inhibitor; NADH dehydrogenase; Phenothiazine; Respiratory chain; Staphylococcus aureus

Indexed keywords

CHLORPROMAZINE; FLAVINE ADENINE NUCLEOTIDE; MENAQUINONE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NITRATE REDUCTASE (NADH); PHENOTHIAZINE; PROTON; QUINONE DERIVATIVE; THIORIDAZINE; TRIFLUOPERAZINE;

ARTICLE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE IDENTIFICATION; GENOME; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PURIFICATION; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); MAMMALIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM TUBERCULOSIS; STAPHYLOCOCCUS AUREUS;

BIOENERGETICS/ELECTRON TRANSFER COMPLEX; ENZYME INHIBITOR; NADH DEHYDROGENASE; PHENOTHIAZINE; RESPIRATORY CHAIN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; INHIBITORY CONCENTRATION 50; NADH DEHYDROGENASE; PHENOTHIAZINES; QUINONE REDUCTASES; STAPHYLOCOCCUS AUREUS;

EID: 84901820211     PISSN: 00052728     EISSN: 18792650     Source Type: Journal    
DOI: 10.1016/j.bbabio.2014.03.017     Document Type: Article

References (80)

1. I. Chopra, L. Hesse, and A.J. O'Neill Exploiting current understanding of antibiotic action for discovery of new drugs Symp. Ser. Soc. Appl. Microbiol. 2002 4S 15S (Pubitemid 34535501)
2. J.G. Hurdle, A.J. O'Neill, I. Chopra, and R.E. Lee Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections Nat. Rev. Microbiol. 9 2011 62 75
3. K. Andries, P. Verhasselt, J. Guillemont, H.W. Gohlmann, J.M. Neefs, H. Winkler, J. Van Gestel, P. Timmerman, M. Zhu, E. Lee, P. Williams, D. de Chaffoy, E. Huitric, S. Hoffner, E. Cambau, C. Truffot-Pernot, N. Lounis, and V. Jarlier A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis Science 307 2005 223 227 (Pubitemid 40116230)
4. H. Angerer, H.R. Nasiri, V. Niedergesass, S. Kerscher, H. Schwalbe, and U. Brandt Tracing the tail of ubiquinone in mitochondrial complex I Biochim. Biophys. Acta 1817 2012 1776 1784
5. R.G. Efremov, and L.A. Sazanov Structure of the membrane domain of respiratory complex I Nature 476 2011 414 420
6. Y. Feng, W. Li, J. Li, J. Wang, J. Ge, D. Xu, Y. Liu, K. Wu, Q. Zeng, J.W. Wu, C. Tian, B. Zhou, and M. Yang Structural insight into the type-II mitochondrial NADH dehydrogenases Nature 491 2012 478 482
7. O. Juarez, and B. Barquera Insights into the mechanism of electron transfer and sodium translocation of the Na(+)-pumping NADH:quinone oxidoreductase Biochim. Biophys. Acta 1817 2012 1823 1832
8. J.M. Villegas, S.I. Volentini, M.R. Rintoul, and V.A. Rapisarda Amphipathic C-terminal region of Escherichia coli NADH dehydrogenase-2 mediates membrane localization Arch. Biochem. Biophys. 505 2011 155 159
9. S. Kerscher, S. Drose, V. Zickermann, and U. Brandt The three families of respiratory NADH dehydrogenases Results Probl. Cell Differ. 45 2008 185 222
10. A. Jaworowski, G. Mayo, D.C. Shaw, H.D. Campbell, and I.G. Young Characterization of the respiratory NADH dehydrogenase of Escherichia coli and reconstitution of NADH oxidase in ndh mutant membrane vesicles Biochemistry 20 1981 3621 3628 (Pubitemid 11058031)
11. A.M. Melo, M. Duarte, and A. Videira Primary structure and characterisation of a 64 kDa NADH dehydrogenase from the inner membrane of Neurospora crassa mitochondria Biochim. Biophys. Acta 1412 1999 282 287 (Pubitemid 29356108)
12. A.G. Rasmusson, A.S. Svensson, V. Knoop, L. Grohmann, and A. Brennicke Homologues of yeast and bacterial rotenone-insensitive NADH dehydrogenases in higher eukaryotes: two enzymes are present in potato mitochondria Plant J. 20 1999 79 87 (Pubitemid 29519959)
13. S.S. Lin, U. Gross, and W. Bohne Type II NADH dehydrogenase inhibitor 1-hydroxy-2-dodecyl-4(1H)quinolone leads to collapse of mitochondrial inner-membrane potential and ATP depletion in Toxoplasma gondii Eukaryot. Cell 8 2009 877 887
14. A.J. Warman, T.S. Rito, N.E. Fisher, D.M. Moss, N.G. Berry, P.M. O'Neill, S.A. Ward, and G.A. Biagini Antitubercular pharmacodynamics of phenothiazines J. Antimicrob. Chemother. 68 2013 869 880
15. D. Bald, and A. Koul Respiratory ATP synthesis: the new generation of mycobacterial drug targets? FEMS Microbiol. Lett. 308 2010 1 7
16. P.S. Shirude, B. Paul, N. Roy Choudhury, C. Kedari, B. Bandodkar, and B.G. Ugarkar Quinolinyl pyrimidines: potent inhibitors of NDH-2 as a novel class of anti-TB agents ACS Med. Chem. Lett. 3 2012 736 740
17. E.A. Weinstein, T. Yano, L.S. Li, D. Avarbock, A. Avarbock, D. Helm, A.A. McColm, K. Duncan, J.T. Lonsdale, and H. Rubin Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs Proc. Natl. Acad. Sci. U. S. A. 102 2005 4548 4553 (Pubitemid 40397149)
18. G.A. Biagini, N. Fisher, A.E. Shone, M.A. Mubaraki, A. Srivastava, A. Hill, T. Antoine, A.J. Warman, J. Davies, C. Pidathala, R.K. Amewu, S.C. Leung, R. Sharma, P. Gibbons, D.W. Hong, B. Pacorel, A.S. Lawrenson, S. Charoensutthivarakul, L. Taylor, O. Berger, A. Mbekeani, P.A. Stocks, G.L. Nixon, J. Chadwick, J. Hemingway, M.J. Delves, R.E. Sinden, A.M. Zeeman, C.H. Kocken, N.G. Berry, P.M. O'Neill, and S.A. Ward Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria Proc. Natl. Acad. Sci. U. S. A. 109 2012 8298 8303
19. S.S. Lin, U. Gross, and W. Bohne Two internal type II NADH dehydrogenases of Toxoplasma gondii are both required for optimal tachyzoite growth Mol. Microbiol. 82 2011 209 221
20. M.A. Fischbach, and C.T. Walsh Antibiotics for emerging pathogens Science 325 2009 1089 1093
21. V. Artzatbanov, and V.V. Petrov Branched respiratory chain in aerobically grown Staphylococcus aureus - oxidation of ethanol by cells and protoplasts Arch. Microbiol. 153 1990 580 584 (Pubitemid 20215808)
22. A. Sasarman, P. Purvis, and V. Portelance Role of menaquinone in nitrate respiration in Staphylococcus aureus J. Bacteriol. 117 1974 911 913
23. Z. Tynecka, Z. Szczesniak, A. Malm, and R. Los Energy conservation in aerobically grown Staphylococcus aureus Res. Microbiol. 150 1999 555 566 (Pubitemid 29510639)
24. T. Yano, S. Kassovska-Bratinova, J.S. Teh, J. Winkler, K. Sullivan, A. Isaacs, N.M. Schechter, and H. Rubin Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species J. Biol. Chem. 286 2011 10276 10287
25. J.R. Fuller, N.P. Vitko, E.F. Perkowski, E. Scott, D. Khatri, J.S. Spontak, L.R. Thurlow, and A.R. Richardson Identification of a lactate-quinone oxidoreductase in Staphylococcus aureus that is essential for virulence Front. Cell. Infect. Microbiol. 1 2011 19
26. W. Balemans, L. Vranckx, N. Lounis, O. Pop, J. Guillemont, K. Vergauwen, S. Mol, R. Gilissen, M. Motte, D. Lancois, M. De Bolle, K. Bonroy, H. Lill, K. Andries, D. Bald, and A. Koul Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria Antimicrob. Agents Chemother. 56 2012 4131 4139
27. T. Yano, L.S. Li, E. Weinstein, J.S. Teh, and H. Rubin Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2) J. Biol. Chem. 281 2006 11456 11463 (Pubitemid 43855400)
28. D. Ordway, M. Viveiros, C. Leandro, M.J. Arroz, and L. Amaral Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus Int. J. Antimicrob. Agents 20 2002 34 43 (Pubitemid 34778465)
29. R.C. Edgar MUSCLE: a multiple sequence alignment method with reduced time and space complexity BMC Bioinforma. 5 2004 113
30. D.T. Jones Protein secondary structure prediction based on position-specific scoring matrices J. Mol. Biol. 292 1999 195 202 (Pubitemid 29435759)
31. H.S. Kim, D. Nagore, and H. Nikaido Multidrug efflux pump MdtBC of Escherichia coli is active only as a B2C heterotrimer J. Bacteriol. 192 2010 1377 1386
32. A. Aliverti, B. Curti, and M.A. Vanoni Identifying and quantitating FAD and FMN in simple and in iron-sulfur-containing flavoproteins Methods Mol. Biol. 131 1999 9 23
33. S. Susin, J. Abian, F. Sanchez-Baeza, M.L. Peleato, A. Abadia, E. Gelpi, and J. Abadia Riboflavin 3′- and 5′-sulfate, two novel flavins accumulating in the roots of iron-deficient sugar beet (Beta vulgaris) J. Biol. Chem. 268 1993 20958 20965 (Pubitemid 23292276)
34. M. Wu, and R.E. Hancock Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane J. Biol. Chem. 274 1999 29 35 (Pubitemid 29035025)
35. R.J. Brooijmans, B. Poolman, G.K. Schuurman-Wolters, W.M. de Vos, and J. Hugenholtz Generation of a membrane potential by Lactococcus lactis through aerobic electron transport J. Bacteriol. 189 2007 5203 5209 (Pubitemid 47076066)
36. E.S. Duthie, and L.L. Lorenz Staphylococcal coagulase; mode of action and antigenicity J. Gen. Microbiol. 6 1952 95 107
37. N.R. Yun, K.Y. San, and G.N. Bennett Enhancement of lactate and succinate formation in adhE or pta-ackA mutants of NADH dehydrogenase-deficient Escherichia coli J. Appl. Microbiol. 99 2005 1404 1412 (Pubitemid 41735719)
38. L. Herron-Olson, J.R. Fitzgerald, J.M. Musser, and V. Kapur Molecular correlates of host specialization in Staphylococcus aureus PLoS One 2 2007 e1120
39. M.G. Rossmann, D. Moras, and K.W. Olsen Chemical and biological evolution of nucleotide-binding protein Nature 250 1974 194 199
40. C.R. Bellamacina The nicotinamide dinucleotide binding motif: a comparison of nucleotide binding proteins FASEB J. 10 1996 1257 1269 (Pubitemid 26307511)
41. S. Ghisla, and V. Massey New flavins for old: artificial flavins as active site probes of flavoproteins Biochem. J. 239 1986 1 12
42. S. Ghisla, V. Massey, J.M. Lhoste, and S.G. Mayhew Fluorescence and optical characteristics of reduced flavines and flavoproteins Biochemistry 13 1974 589 597
43. N.S. Scrutton Identification of covalent flavoproteins and analysis of the covalent link Methods Mol. Biol. 131 1999 181 193
44. C. Griesbeck, M. Schutz, T. Schodl, S. Bathe, L. Nausch, N. Mederer, M. Vielreicher, and G. Hauska Mechanism of sulfide-quinone reductase investigated using site-directed mutagenesis and sulfur analysis Biochemistry 41 2002 11552 11565
45. P. Venkatakrishnan, A.M. Lencina, L.A. Schurig-Briccio, and R.B. Gennis Alternate pathways for NADH oxidation in Thermus thermophilus using type 2 NADH dehydrogenases Biol. Chem. 394 2013 667 676
46. A.M. Lencina, Z. Ding, L.A. Schurig-Briccio, and R.B. Gennis Characterization of the Type III sulfide:quinone oxidoreductase from Caldivirga maquilingensis and its membrane binding Biochim. Biophys. Acta 1827 2012 266 275
47. R. Bentley, and R. Meganathan Biosynthesis of vitamin K (menaquinone) in bacteria Microbiol. Rev. 46 1982 241 280 (Pubitemid 13205002)
48. M. Bekker, G. Kramer, A.F. Hartog, M.J. Wagner, C.G. de Koster, K.J. Hellingwerf, and M.J. de Mattos Changes in the redox state and composition of the quinone pool of Escherichia coli during aerobic batch-culture growth Microbiology 153 2007 1974 1980 (Pubitemid 46952527)
49. R.M. Lorence, J.G. Koland, and R.B. Gennis Coulometric and spectroscopic analysis of the purified cytochrome d complex of Escherichia coli: evidence for the identification of "cytochrome a1" as cytochrome b595 Biochemistry 25 1986 2314 2321 (Pubitemid 16075200)
50. C.W. Jones, and R.K. Poole 10 The analysis of cytochromes T. Bergan, Methods in Microbiology 1985 Academic Press 285 328
51. S.P. Rao, S. Alonso, L. Rand, T. Dick, and K. Pethe The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis Proc. Natl. Acad. Sci. U. S. A. 105 2008 11945 11950
52. S.S. Costa, M. Viveiros, L. Amaral, and I. Couto Multidrug efflux pumps in Staphylococcus aureus: an update Open Microbiol. J. 7 2013 59 71
53. U. Domanska, A. Pobudkowska, and A. Pelczarska Solubility of sparingly soluble drug derivatives of anthranilic acid J. Phys. Chem. B 115 2011 2547 2554
54. J.S. Modica-Napolitano, C.J. Lagace, W.A. Brennan, and J.R. Aprille Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro Arch. Pharm. Res. 26 2003 951 959
55. J. Han, and K. Burgess Fluorescent indicators for intracellular pH Chem. Rev. 110 2010 2709 2728
56. J.P. Dufour, A. Goffeau, and T.Y. Tsong Active proton uptake in lipid vesicles reconstituted with the purified yeast plasma membrane ATPase. Fluorescence quenching of 9-amino-6-chloro-2-methoxyacridine J. Biol. Chem. 257 1982 9365 9371
57. H.J. Apell, and B. Bersch Oxonol VI as an optical indicator for membrane potentials in lipid vesicles Biochim. Biophys. Acta 903 1987 480 494
58. G.W. Kaatz, V.V. Moudgal, S.M. Seo, and J.E. Kristiansen Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus Antimicrob. Agents Chemother. 47 2003 719 726 (Pubitemid 36158106)
59. N.D. Hammer, M.L. Reniere, J.E. Cassat, Y. Zhang, A.O. Hirsch, M. Indriati Hood, and E.P. Skaar Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host MBio 4 2013
60. J. Liu, T.A. Krulwich, and D.B. Hicks Purification of two putative type II NADH dehydrogenases with different substrate specificities from alkaliphilic Bacillus pseudofirmus OF4 Biochim. Biophys. Acta (BBA) Bioenerg. 1777 2008 453 461
61. T. Mogi, K. Matsushita, Y. Murase, K. Kawahara, H. Miyoshi, H. Ui, K. Shiomi, S. Omura, and K. Kita Identification of new inhibitors for alternative NADH dehydrogenase (NDH-II) FEMS Microbiol. Lett. 291 2009 157 161
62. N. Nantapong, A. Otofuji, C.T. Migita, O. Adachi, H. Toyama, and K. Matsushita Electron transfer ability from NADH to menaquinone and from NADPH to oxygen of type II NADH dehydrogenase of Corynebacterium glutamicum Biosci. Biotechnol. Biochem. 69 2005 149 159 (Pubitemid 40383495)
63. A.J. Prongay, D.R. Engelke, and C.H. Williams Jr. Characterization of two active site mutations of thioredoxin reductase from Escherichia coli J. Biol. Chem. 264 1989 2656 2664 (Pubitemid 19057758)
64. A.J. Prongay, and C.H. Williams Jr. Oxidation-reduction properties of Escherichia coli thioredoxin reductase altered at each active site cysteine residue J. Biol. Chem. 267 1992 25181 25188
65. T.J. Jonsson, H.R. Ellis, and L.B. Poole Cysteine reactivity and thiol-disulfide interchange pathways in AhpF and AhpC of the bacterial alkyl hydroperoxide reductase system Biochemistry 46 2007 5709 5721 (Pubitemid 46764120)
66. L. Amaral, M. Viveiros, and J. Molnar Antimicrobial activity of phenothiazines In Vivo 18 2004 725 731
67. D. Takacs, P. Cerca, A. Martins, Z. Riedl, G. Hajos, J. Molnar, M. Viveiros, I. Couto, and L. Amaral Evaluation of forty new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains In Vivo 25 2011 719 724
68. A.T. Fafarman, P.A. Sigala, J.P. Schwans, T.D. Fenn, D. Herschlag, and S.G. Boxer Quantitative, directional measurement of electric field heterogeneity in the active site of ketosteroid isomerase Proc. Natl. Acad. Sci. U. S. A. 109 2012 E299 308
69. L. Amaral, and J. Molnar Why and how the old neuroleptic thioridazine cures the XDR-TB patient Pharmaceuticals (Basel) 5 2012 1021 1031
70. L. Amaral, Z. Udwadia, E. Abbate, and D. van Soolingen The added effect of thioridazine in the treatment of drug-resistant tuberculosis Int. J. Tuberc. Lung Dis. 16 2012 1706 1708 (author reply 1708-1709)
71. P.A. Mak, S.P. Rao, M. Ping Tan, X. Lin, J. Chyba, J. Tay, S.H. Ng, B.H. Tan, J. Cherian, J. Duraiswamy, P. Bifani, V. Lim, B.H. Lee, N. Ling Ma, D. Beer, P. Thayalan, K. Kuhen, A. Chatterjee, F. Supek, R. Glynne, J. Zheng, H.I. Boshoff, C.E. Barry 3rd, T. Dick, K. Pethe, and L.R. Camacho A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis ACS Chem. Biol. 7 2012 1190 1197
72. L. Rodrigues, D. Wagner, M. Viveiros, D. Sampaio, I. Couto, M. Vavra, W.V. Kern, and L. Amaral Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis J. Antimicrob. Chemother. 61 2008 1076 1082 (Pubitemid 351524452)
73. M.M. Kristiansen, C. Leandro, D. Ordway, M. Martins, M. Viveiros, T. Pacheco, J. Molnar, J.E. Kristiansen, and L. Amaral Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump In Vivo 20 2006 361 366 (Pubitemid 43772670)
74. J. Hyttel, J.J. Larsen, A.V. Christensen, and J. Arnt Receptor-binding profiles of neuroleptics Psychopharmacology Suppl. 2 1985 9 18
75. M. Martins, W. Bleiss, A. Marko, D. Ordway, M. Viveiros, C. Leandro, T. Pacheco, J. Molnar, J.E. Kristiansen, and L. Amaral Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study In Vivo 18 2004 787 794 (Pubitemid 40089628)
76. R.H. Thanacoody Thioridazine: the good and the bad Recent Pat. Antiinfect. Drug Discov. 6 2011 92 98
77. L.J. Piddock Multidrug-resistance efflux pumps - not just for resistance Nat. Rev. Microbiol. 4 2006 629 636 (Pubitemid 44317025)
78. P. Mazurkiewicz, G.J. Poelarends, A.J. Driessen, and W.N. Konings Facilitated drug influx by an energy-uncoupled secondary multidrug transporter J. Biol. Chem. 279 2004 103 108 (Pubitemid 38044804)
79. X.Z. Li, and H. Nikaido Efflux-mediated drug resistance in bacteria: an update Drugs 69 2009 1555 1623
80. O. Hendricks, T.S. Butterworth, and J.E. Kristiansen The in-vitro antimicrobial effect of non-antibiotics and putative inhibitors of efflux pumps on Pseudomonas aeruginosa and Staphylococcus aureus Int. J. Antimicrob. Agents 22 2003 262 264 (Pubitemid 37103210)